Cargando…

The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy

BACKGROUND: Universal hepatitis B virus (HBV) vaccination of newborn babies was introduced in Italy in 1991 and was extended to 12-years-old children for the first 12 years of application so as to cover in a dozen years the Italian population aged 0-24 years. The aim of this study was to identify fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coppola, Nicola, Corvino, Anna Rita, De Pascalis, Stefania, Signoriello, Giuseppe, Di Fiore, Eliana, Nienhaus, Albert, Sagnelli, Evangelista, Lamberti, Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376497/ https://www.ncbi.nlm.nih.gov/pubmed/25884719 http://dx.doi.org/10.1186/s12879-015-0874-3

Ejemplares similares

COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression
por: Coppola, Nicola, et al.
Publicado: (2013)

Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme?
por: Lamberti, Monica, et al.
Publicado: (2015)

HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
por: Sagnelli, Caterina, et al.
Publicado: (2021)

Erratum to: Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme?
por: Lamberti, Monica, et al.
Publicado: (2016)

Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy
por: Zampino, Rosa, et al.
Publicado: (2018)

Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy
por: Antonucci, Giorgio, et al.
Publicado: (2013)

Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy
por: Scognamiglio, Paola, et al.
Publicado: (2009)

Prevalence of latent tuberculosis infection in healthcare workers at a hospital in Naples, Italy, a low-incidence country
por: Lamberti, Monica, et al.
Publicado: (2016)

Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
por: Sagnelli, Caterina, et al.
Publicado: (2022)

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
por: Cargill, Tamsin, et al.
Publicado: (2023)

Seroconverting nonresponder of high-dose intramuscular HBV vaccine with intradermal HBV vaccine: A case report
por: Das, Manjusha, et al.
Publicado: (2017)

Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-α as an effective therapeutic vaccine adjuvant
por: Zhao, Weidong, et al.
Publicado: (2018)

Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study
por: Coppola, Nicola, et al.
Publicado: (2016)

Prevalence of HBV and HBV vaccination coverage in health care workers of tertiary hospitals of Peshawar, Pakistan
por: Attaullah, Sobia, et al.
Publicado: (2011)

Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017)

Poly(I:C)/Alum Mixed Adjuvant Priming Enhances HBV Subunit Vaccine-Induced Immunity in Mice When Combined with Recombinant Adenoviral-Based HBV Vaccine Boosting
por: Chuai, Xia, et al.
Publicado: (2013)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

Impact of targeted vaccination on HBV genotypes in Amsterdam
por: Bruisten, S., et al.
Publicado: (2006)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
por: Lalwani, Sanjay K., et al.
Publicado: (2016)

Effectiveness of HBV Vaccination in Infants and Prediction of HBV Prevalence Trend under New Vaccination Plan: Findings of a Large-Scale Investigation
por: Yang, Shi-gui, et al.
Publicado: (2012)

Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
por: Torres-Cornejo, Almudena, et al.
Publicado: (2017)

Inactivated COVID-19 vaccines, HBV and HIV: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
por: Farhad, Tasneem, et al.
Publicado: (2022)

Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice
por: Ito, Daisuke, et al.
Publicado: (2023)

CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
por: Zhao, Huajun, et al.
Publicado: (2022)

Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
por: Ho, Joan Kha-Tu, et al.
Publicado: (2020)

1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
por: Scheifele, David W., et al.
Publicado: (2014)

Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection
por: Hoogeveen, Ruben C., et al.
Publicado: (2020)

Adherence and Effectiveness of HBV Vaccination among Healthcare Workers in Egypt
por: Elshaer, Mohammed, et al.
Publicado: (2021)

Five Decades of HBV Infection in Italy: A Continuous Challenge
por: Stroffolini, Tommaso, et al.
Publicado: (2023)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon
por: Meriki, Henry Dilonga, et al.
Publicado: (2018)

Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy
por: Alessio, Loredana, et al.
Publicado: (2018)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country
por: Stroffolini, Tommaso, et al.
Publicado: (2022)

The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule
por: Chatterjee, Sukanta, et al.
Publicado: (2010)

Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody
por: Laksananun, Nattinee, et al.
Publicado: (2019)

Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection
por: Kosinska, Anna D., et al.
Publicado: (2021)

Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence
por: van der Sande, Marianne A.B., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_n3q0dm598dsk87dihlc7i2jpg8